OBJECTIVE: Tissue inhibitor of metalloproteinase (TIMP)-1 is upregulated in fat of obese rodents and promotes adipose tissue development in these animals. However, it is unclear whether TIMP-1 independently predicts adiposity in humans and whether serum levels are increased in s.c. and visceral obesity. DESIGN: Twenty-four lean, 16 s.c. obese, and 20 visceral obese subjects were studied. METHODS: Plasma TIMP-1 concentrations were quantified using ELISAs and correlated to clinical parameters. RESULTS: Plasma TIMP-1 levels were significantly different between lean (156 +/- 42 microg/l), s.c. obese (186 +/- 52 microg/l), and visceral obese (198 +/- 42 microg/l) subjects (P < 0.01). Furthermore, TIMP-1 correlated positively with body mass index (BMI), waist-to-hip ratio (WHR), % body fat, fasting insulin, free fatty acids, cholesterol, leptin, interleukin-6, and negatively with adiponectin (P < 0.05). Moreover, TIMP-1 serum levels predicted % body fat but not WHR independent of age, sex, and plasma insulin. CONCLUSIONS: We demonstrate that increased TIMP-1 serum levels are found with increased adiposity in humans.
OBJECTIVE:Tissue inhibitor of metalloproteinase (TIMP)-1 is upregulated in fat of obese rodents and promotes adipose tissue development in these animals. However, it is unclear whether TIMP-1 independently predicts adiposity in humans and whether serum levels are increased in s.c. and visceral obesity. DESIGN: Twenty-four lean, 16 s.c. obese, and 20 visceral obese subjects were studied. METHODS: Plasma TIMP-1 concentrations were quantified using ELISAs and correlated to clinical parameters. RESULTS: Plasma TIMP-1 levels were significantly different between lean (156 +/- 42 microg/l), s.c. obese (186 +/- 52 microg/l), and visceral obese (198 +/- 42 microg/l) subjects (P < 0.01). Furthermore, TIMP-1 correlated positively with body mass index (BMI), waist-to-hip ratio (WHR), % body fat, fasting insulin, free fatty acids, cholesterol, leptin, interleukin-6, and negatively with adiponectin (P < 0.05). Moreover, TIMP-1 serum levels predicted % body fat but not WHR independent of age, sex, and plasma insulin. CONCLUSIONS: We demonstrate that increased TIMP-1 serum levels are found with increased adiposity in humans.
Authors: Diane M Jaworski; Olga Sideleva; Holly M Stradecki; Garret D Langlois; Aida Habibovic; Basanthi Satish; William G Tharp; James Lausier; Kyla Larock; Thomas L Jetton; Mina Peshavaria; Richard E Pratley Journal: Endocrinology Date: 2011-02-01 Impact factor: 4.736
Authors: Carrie M Nielson; Jack Wiedrick; Jian Shen; Jon Jacobs; Erin S Baker; Aaron Baraff; Paul Piehowski; Christine G Lee; Arie Baratt; Vladislav Petyuk; Shannon McWeeney; Jeong Youn Lim; Douglas C Bauer; Nancy E Lane; Peggy M Cawthon; Richard D Smith; Jodi Lapidus; Eric S Orwoll Journal: J Bone Miner Res Date: 2017-04-06 Impact factor: 6.741
Authors: Pia S Petersen; Xia Lei; Marcus M Seldin; Susana Rodriguez; Mardi S Byerly; Andrew Wolfe; Scott Whitlock; G William Wong Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-10-15 Impact factor: 3.619
Authors: Isabelle Gerin; Gwendolyn W Louis; Xuan Zhang; Tyler C Prestwich; T Rajendra Kumar; Martin G Myers; Ormond A Macdougald; Warren B Nothnick Journal: Endocrinology Date: 2008-11-26 Impact factor: 4.736
Authors: Even Fjære; Charlotte Andersen; Lene Secher Myrmel; Rasmus Koefoed Petersen; Jakob Bondo Hansen; Hanne Sørup Tastesen; Thomas Mandrup-Poulsen; Nils Brünner; Karsten Kristiansen; Lise Madsen; Maria Unni Rømer Journal: PLoS One Date: 2015-07-13 Impact factor: 3.240